chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Numbness on both feet and hands; Tight feel on the face; Tingling on the whole body; Sore on both shoulders, legs; Sore on both shoulders, legs; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EM9809) via an unspecified route of administration in the right arm on 14Feb2021 at 09:00 (at the age of 39-years-old)  and the patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP7534) via an unspecified route of administration in the right arm on 15Mar2021 at 15:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any concomitant medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Feb2021 at 18:00 the patient experienced numbness on both feet and hands, tight feel on the face, tingling on the whole body and sore on both shoulders and legs. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of numbness on both feet and hands; tight feel on the face, tingling on the whole body and sore on both shoulders and legs were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
pt recv vax & 5APR94 lab test showed inc alpha fetal liver enzymes; f/u info from the MD stated that the pts inc liver function tests occurred a couple of months p/receiving the vax;
I had 2 side effects that lasted for an extended period.  The first was hive-type rash on my arms that I still have in October (5 months after injection). The other is multiple canker sores (mouth ulcers) that began the week of the 2nd injection, and I continue to have 5 months later.
Signs: redness, swelling, wheel like spot the redness area was about 2 inches, the spot was like about the size of a quarter.
Interchange of Product; Pain in left arm/ pain in hand; Pain in elbow; This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (Interchange of Product), PAIN IN EXTREMITY (Pain in left arm/ pain in hand) and ARTHRALGIA (Pain in elbow) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced WRONG PRODUCT ADMINISTERED (Interchange of Product), PAIN IN EXTREMITY (Pain in left arm/ pain in hand) and ARTHRALGIA (Pain in elbow). On 21-Jun-2021, WRONG PRODUCT ADMINISTERED (Interchange of Product), PAIN IN EXTREMITY (Pain in left arm/ pain in hand) and ARTHRALGIA (Pain in elbow) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was not provided.  The action taken with mRNA 1273 with the events was considered as not applicable.
This case involves a patient (unknown demographics) who had "got tired of them making me sick" (illness), after receiving INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious "got tired of them making me sick" (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "I got tired of them making me sick. I'll pass, just like I did on the half accede vaccine."  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were lab data/results available.  It was not reported if the patient received any corrective treatment for the event.  At time of reporting, the outcome was unknown for the event.  There will be no information available on the lot number for this case.
Systemic: Fainting / Unresponsive-Mild, Systemic: light headed, fainted after 5-10mins received vaccine-Mild, Additional Details: After received vaccine 5-10mins, he started feeling light headed, fainted. RN notified him to floor leftside, cold water to back of neck and forehead. BP: 91/66 -90/70, HR 91-85 when left side lying, BP 123/87, Hr 100 when sitting on floor. BP 122/85- 117/83, HR 99-95 when sitting in chair. He went home acoompanied by his mother when feeling better. He has fainted in past with shots and blood draws
No adverse effects noted.  Patient informed that he showed up a week early and that a VAERS report would be filed on his behalf.
died due to heart attack; This is a spontaneous report from a contactable consumer (reporting for her son-in-law) from the Pfizer-sponsored program Pfizer First Connect.  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patients medical history and concomitant medications were not reported.  The patient died due to heart attack on an unspecified date.  The patient died on an unspecified date.  It was unknown if an autopsy was performed.  Follow-up (28Jan2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Reported Cause(s) of Death: died due to heart attack
We have some Moderna Covid-019 vaccine that was given after the expiration date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) in an 87-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.). In October 2021, EXPIRED PRODUCT ADMINISTERED (We have some Moderna Covid-019 vaccine that was given after the expiration date.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported. Reporter has stated that the vaccine was administered between 24Oct2021 - 27Oct2021.
fever, vomiting, fatigue, sever headache and body aches for approximately 12-24 hours after the onset of symptoms (approx after midnight)
I felt hot shortly after getting the vaccine.   I do get hot flashes on occasion, so I attributed it to that plus I was a bit anxious.  After the 15 minute wait, I proceeded to my car.  When I removed my mask, I saw that my cheeks and nose were very red.  By the time I arrived home (about 30 minutes after being vaccinated) the redness had gone down considerably.  I did not even know that this was considered an adverse effect until I saw it online a few weeks after my vaccination.
Pt became dizzy, diaphoretic, hypotensive shortly after vaccine administration. Also c/o ringing in right ear.
Redness, rashes, on upper arm, swelling around elbow area, painful to touch.
This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination. No Medical History information was reported. On 08-Feb-2021 at 2:58 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 08-Feb-2021 at 2:58 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The age of patient was provided as 54.84. Concomitant products were not provided. On 08-Feb-2021 Excursion time was reported at 10:00 A.M and 11 am with temperature as 29 and 35 degrees Fahrenheit, total doses given for the day was 30, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 02-Feb-2021, vial was moved to clinic on 08-Feb-2021. 3 vials were sent to clinic. Vaccine BUD date was 04-Apr-2021. The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F. Treatment medications were not reported. This case was linked to MOD-2022-566976 (Patient Link).
Patient experienced atrial tachycardia the day after the injection that persisted and the following day converted to atrial fibrillation.  Patient does have history of atrial fibrillation but has been well controlled with medication for 2 years.  After conversing with her cardiologist, they decided the atrial tachycardia was a direct result of the Shingrix vaccination and patient was advised to not continue the vaccination series.
swollen injection site arm; splitting headache; a goose egg at the injection site; Chills; soreness at the injection site; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE INDURATION (a goose egg at the injection site), CHILLS (Chills), INJECTION SITE PAIN (soreness at the injection site), INJECTION SITE SWELLING (swollen injection site arm) and HEADACHE (splitting headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (the patient is confident they had Covid-19 on 2 different occasions) in April 2020.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE INDURATION (a goose egg at the injection site), CHILLS (Chills) and INJECTION SITE PAIN (soreness at the injection site). On 07-Feb-2021, the patient experienced INJECTION SITE SWELLING (swollen injection site arm) and HEADACHE (splitting headache). At the time of the report, INJECTION SITE INDURATION (a goose egg at the injection site), CHILLS (Chills), INJECTION SITE PAIN (soreness at the injection site), INJECTION SITE SWELLING (swollen injection site arm) and HEADACHE (splitting headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered INJECTION SITE INDURATION (a goose egg at the injection site), CHILLS (Chills), INJECTION SITE PAIN (soreness at the injection site), INJECTION SITE SWELLING (swollen injection site arm) and HEADACHE (splitting headache) to be possibly related.    Concomitant product information was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-034059, MOD-2021-059296 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up information received on 20-JUL-2021 contains no significant information.
Patient was administered a moderna booster vaccine with a published expiry date of 10/15/2021. PT was observed for 15min after the injection.  No complications were noted and he tolerated the vaccine well.  No adverse events noted.
Vision became double; Muscles in my rayed no longer work together; This is a spontaneous report from a contactable consumer (patient). This 68-year-old, non-pregnant, female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 2, via an unspecified route of administration, administered in left arm on 17Feb2021 at 01:00 PM (age at vaccination of 68 years; lot number: EL6201) as single dose for COVID-19 immunization. Medical history included "IND" from an unknown date, gastrooesophageal reflux disease from an unknown date and unknown if ongoing, arthritis from an unknown date and unknown if ongoing, vestibular vertigo from an unknown date and unknown if ongoing, and type 2 diabetes from an unknown date and unknown if ongoing. Patient had allergies to benzoic acid, vancomycin, moxifloxacin hydrochloride (AVELOX), sulfa, azithromycin (ZITHROMAX), and tree pollen. Patient had not experienced COVID or tested positive for COVID prior to vaccination. Concomitant medication(s) included pravastatin sodium (PRAVASTIN) taken for an unspecified indication, start and stop date were not reported; glimepiride taken for an unspecified indication, start and stop date were not reported; insulin glargine (LANTUS) taken for an unspecified indication, start and stop date were not reported; vitamin D taken for an unspecified indication, start and stop date were not reported; and famotidine (PEPCID AC) taken for an unspecified indication, start and stop date were not reported. Patient had received no other vaccine in four weeks. Patient received the first dose of BNT162b2 (COMIRNATY), via an unspecified route of administration, as a single dose (batch/lot number: unknown) on an unknown date for COVID-19 immunization. The patient reported that three days after her second dose her vision became double on 21Fe2021 at 2:00 PM. She had three MRI's, two MRA's, and blood test and they could not find a cause. The muscles in her "rayed" no longer work together but vision was fine and no diabetic damage. She had not received treatment for vision became double. Not sure if it's from the vaccine but wanted someone to know if it might help. The patient was not recovered from vision became double and muscles in her "rayed" no longer work together.
7X7CM erythematous rash to right anterior thigh. Warm to touch, slightly tender. Firm to center area. Treated with augmentin ES 600/5u 1.5tsp po bid x 7 days.
I went to the pharmacy to get my 2nd shot of COVID, I waited my 30 minutes and went home, I was fine months later the adverse event was noticeable due to that I notice a nodule coming out of my foot above my ankle. I went to my doctor and there was testing done that resulted in a benign tumor on both ankles. I will be having surgery in the next couple of months. I am currently with both ankle swollen and with pain.
Information has been received from a nurse practitioner and a licensed practical nurse concerning a teenage female (age not reported) who on an unspecified date was vaccinated with 0.5 mL of HPV. Subsequently, the patient ended up crying and reported she had pain, when the vaccine was being administered, either left or right arm and had some pain afterwards. The licensed practical nurse further reported that the patient developed pain one hour after the injection. The patient reported that the pain had subsided, however, when the patient went to bed that evening, the pain had returned. Unspecified medical attention was sought. At the time of this report, the patient had fully recovered from the events (date unknown). Follow up information indicated that the patient had no further complaints of pain. Additional information is not expected.
medication ran down the consumer's arm with no reported adverse event; Initial information was received on 11-Nov-2022 regarding an unsolicited valid  non-serious case received from a healthcare professional.  This case involves a 36 years old male patient and reporter reported that medication ran down the consumer's arm with no reported adverse event while receiving vaccine Influenza quadrival A-B vaccine [Fluzone QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 11-Nov-2022, the Influenza quadrival A-B vaccine suspension for injection (intramuscular route in the left arm) (lot UT7716JA and expiration date: 30-Jun-2023) ran down the consumer's arm with no reported adverse event (accidental exposure to product).  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Information has been received from a physician's assistant concerning a 23 year old female with "mild aluminum sensitivity as child and had a reaction to Tdap and pertussis" and a history of Lyme disease in the past and attention deficit disorder (ADD) who on 20-JUL-2010 was vaccinated IM with the first 0.5 ml dose of GARDASIL (lot #665768/1377Y) into her left arm. Concomitant therapy included unspecified birth control medication. "Two weeks after vaccination" on approximately 03-AUG-2010 the patient felt achy all over, joint pain all over and arm pain. The patient thought she was having a reoccurrence of Lyme disease. There were no laboratory studies performed. The patient sought medical attention by calling and visiting the office. The patient was told to use warm compresses and massage. The full body aches went away 1 month after vaccination on approximately 20-AUG-2010. The arm pain that included soreness and tenderness occurred off and on and had not resolved. Follow-up information has been received from a secretary who pulled the chart and reported that no other vaccines were administered with GARDASIL on 20-Jul-2010. The chart showed the patient's last office visit on 20-SEP-2010, at which time the patient told the physician's assistant she would not be getting any further physician's assistant doses. The patient's status was unknown. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a male patient(pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. The pt was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided) on 17-MAR-2014 and 15-APR-2016 at a health center for its intended purpose: the prevention of shingles. ZOSTAVAX did not prevent shingles, but rather caused the pt to contract a persistent strain of herpes zoster and pneumonia. Shortly after vaccination, the pt suffered and was diagnosed with shingles on his left chest to back. The pt also suffered and was diagnosed with pneumonia. The pt sustained severe and permanent personal injuries. As a direct and proximate result of ZOSTAVAX, the pt suffered painful injuries and damages, and required extensive medical care and treatment(details not provided). As a result of the ZOSTAVAX, the pt suffered serious, progressive, permanent and incurable injuries as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical and impairment and injury. Vaccination failure, pneumonia and herpes zoster were considered to be disabling. Upon internal review, pneumonia was determined to be medically significant. Additional information has been requested.
Child received PEDIARIX IM to thigh on 3/18/15. Developed abscess to thigh and pus. Lesion cultured->culture negative. Treated cephalexin, warm compresses.
About 24 hours after receiving the vaccine, I had a fever of 100.4 and chills. This lasted for about 6 hours before bed. I woke up in the morning and the fever and chills were gone. I feel like this was a normal immune response but my employer asked me to fill this out.
Dizziness, Tachycardia, Flushing, sweating, Throat "tingling"  Narrative:
Left arm pain/ right arm was sore for 3-4 days; First dose was given on he believes 14Feb2021. The second dose was on 28Feb2021; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 28Feb2021 (Lot number: EN6203) at the age of 73 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Bnt162b2 (1st dose, Anatomical location: Left arm, Event Verbatim: the pain in the arm after the shot.  No big deal. He got it with first shot too), administration date: 14Feb2021, when the patient was 73 years old, for COVID-19 immunization, reaction(s): "pain in the arm".  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 28Feb2021, outcome "recovering", described as "First dose was given on he believes 14Feb2021. The second dose was on 28Feb2021"; PAIN IN EXTREMITY (non-serious) with onset 01Mar2021, outcome "recovering", described as "Left arm pain/ right arm was sore for 3-4 days".  Additional information: This report was not related to a study or program.  Follow-up attempts are completed. No further information is expected.
Chills, bodyaches,leg cramps - no appetite, arm sore for 3 days- symtoms from friday to sunday- 3 days.
I haven't been sick since 2005. In January 2021 my husband and I were exposed to The Virus for 4 days but neither of us got sick.  I got the COVID vaccine in April 2021.  In June 2021 I had the worst cold I've ever had, took 3 weeks to recover.  Today July 23, 2021 I experienced unexplained nausea, sore throat and dizziness.  I am convinced the vaccine has screwed up my immune system.
3 DAYS FOLLOWING VACCINE, PATIENT HAD A 30 SECOND SEIZURE-LIKE EPISODE
Difficulty breathing, light headed for approx 15 minutes within 5 minutes following immunization.  Fever 102.0, chills,  severe body aches, headache, nausea which started at 11:00 pm on 3/1/21 until approx 2:00 am on 3/3/21. Soreness of injection site started immediately and lasted 5 days. Fatigue started immediately and lasted 7 days.